DIVIDE AND CONQUER
Divide & Conquer is a biotechnology company based in Cambridge, UK and working in collaboration with the University of Heidelberg and German Cancer Research Center (DKFZ). The company is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumours with very poor life expectancy. Divide & Conquer is funded by VC firm Medicxi.
DIVIDE AND CONQUER
Industry:
Biotechnology Health Care Hospital
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.conquer.bio
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
10 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Content Delivery Network Euro Google Maps JsDelivr Sectigo SSL Sectigo Domain SSL
Current Advisors List
Founder
Investors List
Medicxi
Medicxi investment in Series A - Divide and Conquer
Official Site Inspections
http://www.conquer.bio Semrush global rank: 6 M Semrush visits lastest month: 1.36 K
- Host name: pineapple.catalyst2.com
- IP address: 84.18.207.37
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Divide and Conquer"
ConquestBio
Our ambition is to conquer and design drugs against 4000+ targets with known co-crustal structures to design and develop small molecular drugs that are orally available, safe and …See details»
Home | Conquer Cancer, the ASCO Foundation
Conquer Cancer®, the ASCO Foundation, is registered in Virginia as a nonprofit corporation. Conquer Cancer is a public charity exempt from federal income tax under Section 501(c)(3) of the Internal Revenue Code and the organization’s …See details»
A Conversation With Conquer Cancer CEO Nancy Daly: …
May 25, 2023 Conquer Cancer®, the ASCO Foundation, is registered in Virginia as a nonprofit corporation. Conquer Cancer is a public charity exempt from federal income tax under Section 501(c)(3) of the Internal Revenue Code and …See details»
GenAI Driven Platform for Drug Design - conquest-bio.com
We design and test drugs that inhibit protein-protein interactions that drive the pathological progression of serious diseases affecting the human population.See details»
Conquer Cancer, the ASCO Foundation
2021 was a year of renewal for Conquer Cancer. As donors matched our passions with their generosity, we made a commitment to double our investment in cancer research and vital …See details»
Divide and Conquer - Crunchbase Company Profile
Divide & Conquer is a biotechnology company based in Cambridge, UK and working in collaboration with the University of Heidelberg and German Cancer …See details»
Conquer - Crunchbase Company Profile & Funding
Conquer is a Canadian charity bike ride whose proceeds are donated to help fight cancer. New. Resources. ... Log In. Experience the new Crunchbase, powered by AI . Experience the new …See details»
Conquer Cancer, the ASCO Foundation - Health …
Organization Overview www.conquer.org. Conquer Cancer®, the ASCO Foundation, funds research into every facet of cancer to benefit every patient, everywhere. In 1964, seven oncologists created the American Society of …See details»
Conquer Cancer, the ASCO Foundation
When Conquer Cancer launched 25 years ago, it was with a critical understanding: Research Conquers Cancer.™ Lifesaving research is only possible, however, when the people behind it have the resources and funding …See details»
Conquer Cancer Announces 2025 ASCO Annual Meeting Merit …
Apr 17, 2025 Conquer Cancer®, the ASCO Foundation, is registered in Virginia as a nonprofit corporation. Conquer Cancer is a public charity exempt from federal income tax under Section …See details»
Conquer Cancer (@conquercancerfoundation) - Instagram
Last year, she participated in the ASCO Oncology Summer Internship (OSI) program funded by Conquer Cancer, providing hands-on training in clinical oncology. Programs like this one are …See details»
Collaborative National Quality and Efficacy Registry (CONQUER) …
A .gov website belongs to an official government organization in the United States . Secure .gov websites use HTTPS ... 144 baseline blood samples (95.4% of cohort) had been stored in the …See details»
Home - Conqueror Biopharma
We Develop Potent Tumor Specific RNA Degraders. Precision Cancer Treatment: Safe, Non-Immunogenic, Tumor-Targeted. Beyond ADC and ImmunotherapySee details»
Organizations | Conquer Cancer, the ASCO Foundation
Feb 2, 2025 Conquer Cancer®, the ASCO Foundation, is registered in Virginia as a nonprofit corporation. Conquer Cancer is a public charity exempt from federal income tax under Section 501(c)(3) of the Internal Revenue Code and the organization’s Federal Identification Number (EIN) is 31-1667995.See details»
Conquer Cancer, the ASCO Foundation
In 2022 alone, through your support, Conquer Cancer awarded more than $12 million in funding to 400+ recipients both in the U.S. and internationally, enabling them to press forward in …See details»
CONQUER - Bioinformatics DB
CONQUER (COmprehensive iNtegration of QUEry Results) is a sophisticated R package designed to enhance the interpretation of genetic influences on traits, particularly in the …See details»
ConquerAb Inc. - BIO International Convention 2025
Lead Product in Development: Multiplexed rapid diagnostic for detection of antibodies against therapeutic proteins used for rheumatoid arthritis treatment.See details»
Accelerating breakthroughs in lifesaving research - Conquer …
Feb 10, 2025 Conquer Cancer, the ASCO Foundation shared a post on LinkedIn: “At Conquer Cancer, our mission is to accelerate breakthroughs in lifesaving research and empower people …See details»
Meet the Researchers | Conquer Cancer, the ASCO Foundation
Conquer Cancer®, the ASCO Foundation, is registered in Virginia as a nonprofit corporation. Conquer Cancer is a public charity exempt from federal income tax under Section 501(c)(3) of the Internal Revenue Code and the organization’s Federal Identification Number (EIN) is 31-1667995.See details»
Conquer Cancer, the ASCO Foundation
The commitment of Conquer Cancer donors in support of our critical work has allowed us to adopt the statements confidently. In 2021, Conquer Cancer invested more than $26 million to …See details»